Product Code: PM1752
Title:
COVID-19 Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Sample Type (Nasopharyngeal (NP) Swab, Oropharyngeal (OP) Swab, Nasal Swabs, Blood, Others); By Product & Service Type; By Test Type; By Mode; By End Use; By Regions; Segment Forecast, 2020 - 2027.
The global COVID-19 diagnostics market size is expected to reach USD 23.67 billion by 2027 according to a new study by Polaris Market Research. The report "COVID-19 Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product & Service Type (Instruments, Reagents & Kits, Service); By Sample Type (Nasopharyngeal (NP) Swab, Oropharyngeal (OP) Swab, Nasal Swabs, Blood, Others); By Test Type (Molecular (PCR) Testing, Antigen-based Testing, Antibody (Serology) Testing, Others); By Mode; By End Use; By Regions; Segment Forecast, 2020 - 2027" gives a detailed insight into current market dynamics and provides analysis on future market growth.
COVID-19 medical tests play an important role in management of coronavirus and thus helping in containing the virus infection. These tests are available as POC and non-POC across various healthcare settings such as hospitals, diagnostic centers, physician clinics, and research laboratories. POC test are comparatively easier than the other swab-based tests but they lack sensitivity and specificity thus providing a non-conclusive result.
While these tests are useful in real-time monitoring of infection as a preliminary test, the swab-based tests are necessity for confirmation of COVID-19 infection as they incorporate RT-PCR technology, which provide accurate results. The recent requirements for COVID-19 tests are higher accuracy, faster results, low-cost, and high sensitivity towards coronavirus.
The market drivers for COVID-19 diagnostic includes rapidly increasing COVID-19 infections across the globe, increasing number of patients undergoing diagnosis, government initiatives such as Sero testing, increased preference of physicians and patients towards POC testing, and increased requirement for COVID-19 test by non-profit organizations.
According to World Health Organization (WHO) as of September there were 29 million cases of COVID-19 infections worldwide, affecting about 213 countries and increasing rapidly. The relaxation in lockdowns across the countries and increasing number of testing is expected to drive the demand for COVID-19 diagnostics market. In addition, emergence of second wave of infections in Europe is likely to have a positive impact on the market growth.
Companies such as Cepheid, 1drop Inc., ALDATU BIOSCIENCES, Altona Diagnostics GmbH, Perkin Elmer, Inc., bioMerieux SA, Danaher, Hologic Inc., Abbott, Luminex Corporation, ADT Biotech, Mylab Discovery Solutions Pvt Ltd., Laboratory Corporation of America Holdings, Quest Diagnostics, Quidel, Neuberg Diagnostics, Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd. and Veredus Laboratories are some of the key players operating in the market.
Key market participants are currently focusing on manufacturing and distribution of diagnostic test kits and service to cater to ever increasing demand in pandemic across the globe. In March 2020, Roche shipped its first set of diagnostic kits namely Cobas SARS-CoV-2, of which about 400,000 kits were shipped to in-network distributors across the U.S. ensuring faster reach to the end-users.
Additionally, some biotech companies are launching new PoC diagnostic tests, for instance, E25Bio, a U.S.-based Biotech firm has developed a new test which provides conclusive results within 15 minutes. In addition, Germany-based diagnostic equipment manufacturer Bosch has developed a rapid testing kit for COVID-19 which claims to detect virus within two and a half hours, such initiatives and product launch are expected to increase over the coming years.
Polaris Market Research has segmented the Covid-19 diagnostics market report on the basis of product & service, sample type, test type, mode, & end-use
COVID-19 Diagnostics Product & Service Outlook (Revenue - USD Million, 2016 - 2027)
Instruments
Reagents & Kits
Service
COVID-19 Diagnostics Sample Type Outlook (Revenue - USD Million, 2016 - 2027)
Nasopharyngeal (NP) swab
Oropharyngeal (OP) swab
Nasal Swabs
Blood
Others
COVID-19 Diagnostics Test Type Outlook (Revenue - USD Million, 2016 - 2027)
Molecular (PCR) Testing
Antigen-based Testing
Antibody (Serology) Testing
Others
COVID-19 Diagnostics Mode Outlook (Revenue - USD Million, 2016 - 2027)
Point-of-Care (PoC)
Non Point-of-Care (Non-PoC)
COVID-19 Diagnostics End-Use Outlook (Revenue - USD Million, 2016 - 2027)
Laboratories
Hospitals
Diagnostic Centers and Clinics
Research Institutes
COVID-19 Diagnostics Regional Outlook (Revenue - USD Million, 2016 - 2027)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Russia
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Central & South America
Mexico
Brazil
Argentina
Middle East & Africa
Iran
Saudi Arabia
Iraq
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Data Sources
- 3.2.2. Secondary Data Sources
4. COVID-19 Diagnostics Market Insights
- 4.1. COVID-19 Diagnostics - Industry snapshot
- 4.2. COVID-19 Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. COVID infections
- 4.2.1.2. Increased usage in pharmaceutical industry
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of tests
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. COVID-19 Diagnostics Market Industry trends
5. COVID-19 Diagnostics Market Assessment by Product & Service
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global COVID-19 Diagnostics Market, By Product & Service, 2019 - 2027 (USD Million)
- 5.3. Instruments
- 5.3.1. Global COVID-19 Diagnostics Market, by Instruments, by Region, 2019 - 2027 (USD Million)
- 5.4. Reagents & Kits
- 5.4.1. Global COVID-19 Diagnostics Market, by Reagents & Kits, by Region, 2019 - 2027 (USD Million)
- 5.5. Service
- 5.5.1. Global COVID-19 Diagnostics Market, by Service, by Region, 2019 - 2027 (USD Million)
6. Global COVID-19 Diagnostics Market, by Sample Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 6.3. Nasopharyngeal (NP) Swab
- 6.3.1. Global COVID-19 Diagnostics Market, by Nasopharyngeal (NP) Swab, By Region, 2019 - 2027 (USD Million)
- 6.4. Oropharyngeal (OP) Swab
- 6.4.1. Global COVID-19 Diagnostics Market, by Oropharyngeal (OP) Swab, by Region, 2019 - 2027 (USD Million)
- 6.5. Nasal Swabs
- 6.5.1. Global COVID-19 Diagnostics Market, by Nasal Swabs, by Region, 2019 - 2027 (USD Million)
- 6.6. Blood
- 6.6.1. Global COVID-19 Diagnostics Market, by Blood, by Region, 2019 - 2027 (USD Million)
- 6.7. Others
- 6.7.1. Global COVID-19 Diagnostics Market, by Others, by Region, 2019 - 2027 (USD Million)
7. Global COVID-19 Diagnostics Market, by Test Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 7.3. Molecular (PCR) Testing
- 7.3.1. Global COVID-19 Diagnostics Market, by Molecular (PCR) Testing, By Region, 2019 - 2027 (USD Million)
- 7.4. Antigen-based Testing
- 7.4.1. Global COVID-19 Diagnostics Market, by Antigen-based Testing, by Region, 2019 - 2027 (USD Million)
- 7.5. Antibody (Serology) Testing
- 7.5.1. Global COVID-19 Diagnostics Market, by Antibody (Serology) Testing, by Region, 2019 - 2027 (USD Million)
- 7.6. Antigen-based Testing
- 7.6.1. Global COVID-19 Diagnostics Market, by Antigen-based Testing, by Region, 2019 - 2027 (USD Million)
- 7.7. Others
- 7.7.1. Global COVID-19 Diagnostics Market, by Others, by Region, 2019 - 2027 (USD Million)
8. Global COVID-19 Diagnostics Market, by Mode
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global COVID-19 Diagnostics Market, By Mode, 2019 - 2027 (USD Million)
- 8.3. Point-of-Care (POC)
- 8.3.1. Global COVID-19 Diagnostics Market, by Point-of-Care (POC), By Region, 2019 - 2027 (USD Million)
- 8.4. Non-Point-of-Care (Non-PoC)
- 8.4.1. Global COVID-19 Diagnostics Market, by Non-Point-of-Care (Non-PoC), by Region, 2019 - 2027 (USD Million)
9. COVID-19 Diagnostics Market Assessment by End Use
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 9.3. Laboratories
- 9.3.1. Global COVID-19 Diagnostics Market, by Laboratories, by Region, 2019 - 2027 (USD Million)
- 9.4. Hospitals
- 9.4.1. Global COVID-19 Diagnostics Market, by Hospitals, by Region, 2019 - 2027 (USD Million)
- 9.5. Diagnostic Centers and Clinics
- 9.5.1. Global COVID-19 Diagnostics Market, by Diagnostic Centers and Clinics, by Region, 2019 - 2027 (USD Million)
- 9.6. Research Institutes
- 9.6.1. Global COVID-19 Diagnostics Market, by Research Institutes, by Region, 2019 - 2027 (USD Million)
10. COVID-19 Diagnostics Market Assessment by Geography
- 10.1. Key findings
- 10.2. Introduction
- 10.2.1. COVID-19 Diagnostics Market Assessment, By Geography, 2019 - 2027 (USD Million)
- 10.3. COVID-19 Diagnostics Market - North America
- 10.3.1. North America: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.3.2. North America: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.3.3. North America: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.3.4. North America: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.3.5. COVID-19 Diagnostics Market - U.S.
- 10.3.5.1. U.S.: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.3.5.2. U.S.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.3.5.3. U.S.: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.3.5.4. U.S.: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.3.6. COVID-19 Diagnostics Market - Canada
- 10.3.6.1. Canada: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.3.6.2. Canada.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.3.6.3. Canada: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.3.6.4. Canada: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.4. COVID-19 Diagnostics Market - Europe
- 10.4.1. Europe: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.4.2. Europe.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.4.3. Europe: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.4.4. Europe: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.4.5. COVID-19 Diagnostics Market - UK
- 10.4.5.1. UK: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.4.5.2. UK.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.4.5.3. UK: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.4.5.4. UK: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.4.6. COVID-19 Diagnostics Market - France
- 10.4.6.1. France: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.4.6.2. France.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.4.6.3. France: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.4.6.4. France: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.4.7. COVID-19 Diagnostics Market - Germany
- 10.4.7.1. Germany: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.4.7.2. Germany.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.4.7.3. Germany: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.4.7.4. Germany: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.4.8. COVID-19 Diagnostics Market - Italy
- 10.4.8.1. Italy: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.4.8.2. Italy.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.4.8.3. Italy: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.4.8.4. Italy: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.4.9. COVID-19 Diagnostics Market - Spain
- 10.4.9.1. Spain: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.4.9.2. Spain.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.4.9.3. Spain: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.4.9.4. Spain: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.4.10. COVID-19 Diagnostics Market - Netherlands
- 10.4.10.1. Netherlands: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.4.10.2. Netherlands.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.4.10.3. Netherlands: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.4.10.4. Netherlands: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.4.11. COVID-19 Diagnostics Market - Russia
- 10.4.11.1. Russia: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.4.11.2. Russia.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.4.11.3. Russia: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.4.11.4. Russia: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.5. COVID-19 Diagnostics Market - Asia-Pacific
- 10.5.1. Asia Pacific: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.5.2. Asia Pacific.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.5.3. Asia-pacific: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.5.4. Asia-pacific: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.5.5. COVID-19 Diagnostics Market - China
- 10.5.5.1. China: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.5.5.2. China.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.5.5.3. China: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.5.5.4. China: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.5.6. COVID-19 Diagnostics Market - India
- 10.5.6.1. India: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.5.6.2. India.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.5.6.3. India: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.5.6.4. India: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.5.7. COVID-19 Diagnostics Market - Malaysia
- 10.5.7.1. Malaysia: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.5.7.2. Malaysia.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.5.7.3. Malaysia: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.5.7.4. Malaysia: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.5.8. COVID-19 Diagnostics Market - Japan
- 10.5.8.1. Japan: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.5.8.2. Japan.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.5.8.3. Japan: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.5.8.4. Japan: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.5.9. COVID-19 Diagnostics Market - Indonesia
- 10.5.9.1. Indonesia: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.5.9.2. Indonesia.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.5.9.3. Indonesia: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.5.9.4. Indonesia: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.5.10. COVID-19 Diagnostics Market - South Korea
- 10.5.10.1. South Korea: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.5.10.2. South Korea.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.5.10.3. South Korea: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.5.10.4. South Korea: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.6. COVID-19 Diagnostics Market - Middle East & Africa
- 10.6.1. Middle East & Africa: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.6.2. Middle East & Africa.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.6.3. Middle East & Africa: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.6.4. Middle East & Africa: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.6.5. COVID-19 Diagnostics Market - Saudi Arabia
- 10.6.5.1. Saudi Arabia: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.6.5.2. Saudi Arabia.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.6.5.3. Saudi Arabia: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.6.5.4. Saudi Arabia: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.6.6. COVID-19 Diagnostics Market - IRAN
- 10.6.6.1. IRAN: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.6.6.2. IRAN.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.6.6.3. IRAN: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.6.6.4. IRAN: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.6.7. COVID-19 Diagnostics Market - Iraq
- 10.6.7.1. Iraq: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.6.7.2. Iraq.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.6.7.3. Iraq: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.6.7.4. Iraq: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.6.8. COVID-19 Diagnostics Market - South Africa
- 10.6.8.1. South Africa: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.6.8.2. South Africa.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.6.8.3. South Africa: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.6.8.4. South Africa: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.7. COVID-19 Diagnostics Market - Latin America
- 10.7.1. Latin America: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.7.2. Latin America.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.7.3. Latin America: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.7.4. Latin America: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.7.5. COVID-19 Diagnostics Market - Mexico
- 10.7.5.1. Mexico: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.7.5.2. Mexico.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.7.5.3. Mexico: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.7.5.4. Mexico: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.7.6. COVID-19 Diagnostics Market - Brazil
- 10.7.6.1. Brazil: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.7.6.2. Brazil.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.7.6.3. Brazil: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.7.6.4. Brazil: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
- 10.7.7. COVID-19 Diagnostics Market - Argentina
- 10.7.7.1. Argentina: COVID-19 Diagnostics Market, By Product and Service Type, 2019 - 2027 (USD Million)
- 10.7.7.2. Argentina.: COVID-19 Diagnostics Market, By Sample Type, 2019 - 2027 (USD Million)
- 10.7.7.3. Argentina: COVID-19 Diagnostics Market, By Test Type, 2019 - 2027 (USD Million)
- 10.7.7.4. Argentina: COVID-19 Diagnostics Market, By End Use, 2019 - 2027 (USD Million)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisiton
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Altona Diagnostics GmbH
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product/Service Benchmarking
- 12.1.4. Recent Development
- 12.2. Perkin Elmer, Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product/Service Benchmarking
- 12.2.4. Recent Development
- 12.3. bioMerieux SA
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product/Service Benchmarking
- 12.3.4. Recent Development
- 12.4. Luminex Corporation
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product/Service Benchmarking
- 12.4.4. Recent Development
- 12.5. ADT Biotech
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product/Service Benchmarking
- 12.5.4. Recent Development
- 12.6. Mylab Discovery Solutions Pvt Ltd
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product/Service Benchmarking
- 12.6.4. Recent Development
- 12.7. Laboratory Corporation of America Holdings
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product/Service Benchmarking
- 12.7.4. Recent Development
- 12.8. Quest Diagnostics
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product/Service Benchmarking
- 12.8.4. Recent Development
- 12.9. Neuberg Diagnostics
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product/Service Benchmarking
- 12.9.4. Recent Development
- 12.10. Thermo Fisher Scientific, Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product/Service Benchmarking
- 12.10.4. Recent Development